At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14 enrolled
Drug / intervention
SMA visitsbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Group Visits to Improve Technology Use, Glycemic Control, and Quality of Life in High Risk Children With Type 1 Diabetes
In Brief
A clinical study evaluating SMA visits for Type 1 Diabetes. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The investigators propose to conduct a pilot prospective cohort study to assess the impact of shared medical appointments (SMA) visits in underserved youth with poorly controlled type 1 diabetes (T1D). The trial will employ an enrollment visit, SMA visits every 3 months over a 12 month study period, followed by a 6-month observational period to assess feasibility and acceptability of SMA and the impact on glycemic control, self-management skills, and health related quality of life.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
CollaboratorsAmerican Diabetes Association, DexCom, Inc.
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartFeb 2022
First PostedJun 2022
Primary CompletionJul 2025
TodayJul 2026
First PostedJun 24, 2022
Enrollment StartFeb 16, 2022
Primary CompletionJul 1, 2025
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 4.0 years ago
Interventions
SMA visitsbehavioral
SMA visit once every 3 months over a 12 month period